The suspension of trading in the securities of Imagion Biosystems Limited (‘IBX’) will be lifted immediately, following the release by IBX of an announcement regarding a proposed capital raising.
View the Reinstatement to Official Quotation announcement.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal